Reach Us +44-1202-068036
Conserved Features Of Cancer Cells Definetheirsensitivityto HAMLET-induceddeath; C-Myc And Glycolysis | 8023
ISSN: 2153-0769

Metabolomics:Open Access
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Conserved features of cancer cells definetheirsensitivityto HAMLET-induceddeath; c-Myc and glycolysis

International Conference and Exhibition on Metabolomics & Systems Biology

P Storm, S Aits, M K Puthia, A Urbano, T Northen, S Powers, B Bowen, Y Chao, W Reindl, D Y Lee, N L Sullivan, J Zhang, M Trulsson, H Yang, J D Watson and C Svanborg

Posters: J Comput Sci Syst Biol

DOI: 10.4172/0975-0851.S1.10

HAMLET is the firstmember of a new family of tumoricidal protein?lipid complexesthatkill cancer cells broadly, whilesparinghealthy, differentiated cells. Many and diverse tumor cell typesare sensitive to the lethaleffect, suggestingthat HAMLET identifies and activatesconserveddeathpathways in cancer cells. Here, weinvestigated the molecular basis for the difference in sensitivitybetween cancer cells and healthy cells. Using a combination of small-hairpin RNA (shRNA) inhibition, proteomic and metabolomictechnology, weidentified the c-Myc oncogene as oneessential determinant of HAMLET sensitivity. Increased c-Myc expression levelspromotedsensitivityto HAMLET and shRNA knockdown of c-Myc suppressed the lethalresponse, suggestingthatoncogenic transformation with c-Myc creates a HAMLET-sensitive phenotype. Furthermore, HAMLET sensitivitywasmodified by the glycolyticstate of tumor cells. Glucose deprivation sensitizedtumor cells to HAMLET- induced cell death and in the shRNA screen, hexokinase 1 (HK1), 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 and hypoxia-induciblefactor 1α modified HAMLET sensitivity. HK1 wasshownto bind HAMLET in a protein arraycontaining ~8000 targets, and HK activitydecreasedwithin 15 min of HAMLET treatment, beforemorphologicalsigns of tumor cell death. In parallel, HAMLET triggered rapid metabolic paralysis in carcinoma cells. Tumor cells werealsoshowntocontainlargeamounts of oleicacid and itsderivativesalreadyafter 15 min. The resultsidentify HAMLET as a novel anti-cancer agent thatkillstumor cells by exploitingunifying features of cancer cells such as oncogeneaddiction or the Warburg effect.
Petter Storm is a PhD student studying the effects of HAMLET on tumor cell metabolism usingvariousomicstechniquesincludingmicroarrays and massspectrometry/metabolomics.
Leave Your Message 24x7